225 related articles for article (PubMed ID: 22791714)
1. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10.
Liu C; Zhang X; Huang F; Yang B; Li J; Liu B; Luo H; Zhang P; Zhang H
J Biol Chem; 2012 Aug; 287(35):29373-83. PubMed ID: 22791714
[TBL] [Abstract][Full Text] [Related]
2. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.
Chen C; Ma X; Hu Q; Li X; Huang F; Zhang J; Pan T; Xia J; Liu C; Zhang H
Retrovirology; 2017 Dec; 14(1):56. PubMed ID: 29258557
[TBL] [Abstract][Full Text] [Related]
3. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.
Izumi T; Burdick R; Shigemi M; Plisov S; Hu WS; Pathak VK
J Virol; 2013 Oct; 87(20):11047-62. PubMed ID: 23926332
[TBL] [Abstract][Full Text] [Related]
4. Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members.
Huang J; Liang Z; Yang B; Tian H; Ma J; Zhang H
J Biol Chem; 2007 Nov; 282(46):33632-33640. PubMed ID: 17848567
[TBL] [Abstract][Full Text] [Related]
5. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
[TBL] [Abstract][Full Text] [Related]
6. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages.
Burdick R; Smith JL; Chaipan C; Friew Y; Chen J; Venkatachari NJ; Delviks-Frankenberry KA; Hu WS; Pathak VK
J Virol; 2010 Oct; 84(19):10241-53. PubMed ID: 20668078
[TBL] [Abstract][Full Text] [Related]
7. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
[TBL] [Abstract][Full Text] [Related]
8. Characterization of APOBEC3G binding to 7SL RNA.
Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
[TBL] [Abstract][Full Text] [Related]
9. GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.
Maeda K; Almofty SA; Singh SK; Eid MMA; Shimoda M; Ikeda T; Koito A; Pham P; Goodman MF; Sakaguchi N
J Immunol; 2013 Dec; 191(12):6030-6039. PubMed ID: 24198285
[TBL] [Abstract][Full Text] [Related]
10. APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
Strebel K; Khan MA
Retrovirology; 2008 Jul; 5():55. PubMed ID: 18597677
[TBL] [Abstract][Full Text] [Related]
11. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
12. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.
Zhang W; Du J; Yu K; Wang T; Yong X; Yu XF
J Virol; 2010 Dec; 84(24):12903-13. PubMed ID: 20926562
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
Zhang H
Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
[TBL] [Abstract][Full Text] [Related]
14. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
[TBL] [Abstract][Full Text] [Related]
15. Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses.
Arjan-Odedra S; Swanson CM; Sherer NM; Wolinsky SM; Malim MH
Retrovirology; 2012 Jun; 9():53. PubMed ID: 22727223
[TBL] [Abstract][Full Text] [Related]
16. NF90 interacts with components of RISC and modulates association of Ago2 with mRNA.
Grasso G; Akkawi C; Franckhauser C; Nait-Saidi R; Bello M; Barbier J; Kiernan R
BMC Biol; 2022 Sep; 20(1):194. PubMed ID: 36050755
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.
Shirakawa K; Takaori-Kondo A; Yokoyama M; Izumi T; Matsui M; Io K; Sato T; Sato H; Uchiyama T
Nat Struct Mol Biol; 2008 Nov; 15(11):1184-91. PubMed ID: 18836454
[TBL] [Abstract][Full Text] [Related]
18. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.
Gallois-Montbrun S; Kramer B; Swanson CM; Byers H; Lynham S; Ward M; Malim MH
J Virol; 2007 Mar; 81(5):2165-78. PubMed ID: 17166910
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.
Pery E; Sheehy A; Nebane NM; Brazier AJ; Misra V; Rajendran KS; Buhrlage SJ; Mankowski MK; Rasmussen L; White EL; Ptak RG; Gabuzda D
J Biol Chem; 2015 Apr; 290(16):10504-17. PubMed ID: 25724652
[TBL] [Abstract][Full Text] [Related]
20. Serine 970 of RNA helicase MOV10 is phosphorylated and controls unfolding activity and fate of mRNAs targeted for AGO2-mediated silencing.
Nawaz A; Kenny PJ; Shilikbay T; Reed M; Stuchlik O; Pohl J; Ceman S
J Biol Chem; 2023 Apr; 299(4):104577. PubMed ID: 36871759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
